Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Keith S. Pentlow"'
Autor:
Philipp Backhaus, Keith S. Pentlow, Alan L Ho, Audrey Mauguen, James A Fagin, Naga Vara Kishore Pillarsetty, Serge K. Lyashchenko, Eva Burnazi, Ronald A. Ghossein, Shalini Chhabra, Murad Abusamra, Steven M. Larson, Heiko Schöder, Joseph O’Donoghue, Wolfgang Weber, Ravinder K. Grewal
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Background Fluorine 18-labelled tetrafluoroborate ([18F]TFB) is a substrate for the sodium/iodide symporter. In thyroid cancer, [18F]TFB-PET/CT may be an alternative to iodine imaging to evaluate the extent of disease, eligibility for radioi
Externí odkaz:
https://doaj.org/article/478716ece8d34d68925bb38dff772cb6
Autor:
Vatche, Tchekmedyian, Lara, Dunn, Eric, Sherman, Shrujal S, Baxi, Ravinder K, Grewal, Steven M, Larson, Keith S, Pentlow, Sofia, Haque, R Michael, Tuttle, Mona M, Sabra, Stephanie, Fish, Laura, Boucai, Jamie, Walters, Ronald A, Ghossein, Venkatraman E, Seshan, Jeffrey A, Knauf, David G, Pfister, James A, Fagin, Alan L, Ho
Publikováno v:
Thyroid
BACKGROUND: Oncogenic activation of mitogen-activated protein kinase (MAPK) signaling is associated with radioiodine refractory (RAIR) thyroid cancer. Preclinical models suggest that activation of the receptor tyrosine kinase erbB-3 (HER3) mitigates
Autor:
Vatche Tchekmedyian, Lara Dunn, Eric Sherman, Shrujal S. Baxi, Ravinder K. Grewal, Steven M. Larson, Keith S. Pentlow, Sofia Haque, R. Michael Tuttle, Mona M. Sabra, Stephanie Fish, Laura Boucai, Jamie Walters, Ronald A. Ghossein, Venkatraman E. Seshan, Jeffrey A. Knauf, David G. Pfister, James A. Fagin, Alan L. Ho
Publikováno v:
Thyroid. 32:273-282
Publikováno v:
EJNMMI Physics, Vol 8, Iss 1, Pp 1-14 (2021)
EJNMMI Physics
EJNMMI Physics
Background The goal of this work was to determine the quantitative accuracy and optimal reconstruction parameters for 124I-PET imaging in the presence of therapeutic levels of 131I. In this effort, images were acquired on a GE D710 PET/CT scanner usi
Autor:
Neeta Pandit-Taskar, Milan Grkovski, Pat B. Zanzonico, Keith S. Pentlow, Shakeel Modak, Kim Kramer, John L. Humm
Publikováno v:
Journal of Nuclear Medicine. :jnumed.122.265131
Autor:
Kim Kramer, Zhigang Zhang, Alex Mak Fung, Jason S. Lewis, Pat Zanzonico, Nai-Kong V. Cheung, Keith S. Pentlow, Steven M. Larson, John L. Humm, Milan Grkovski, Neeta Pandit-Taskar, Jorge A. Carrasquillo, Edward K. Fung, Weiji Shi, Serge K. Lyashchenko
Publikováno v:
Journal of Nuclear Medicine. 60:1794-1801
Radiation dose estimations are key for optimizing therapies. We studied the role of 124I-omburtamab (8H9) given intraventricularly in assessing the distribution and radiation doses before 131I-omburtamab therapy in patients with metastatic leptomenin
Autor:
Bharat Burman, R. Michael Tuttle, Ravinder K Grewal, Eric Jeffrey Sherman, Shrujal S. Baxi, Laura Boucai, Mona Sabra, Stephanie Fish, Keith S. Pentlow, Sofia Haque, Irina Ostrovnaya, Ronald A Ghossein, Helen X. Chen, John Humm, Michael Anthony Carducci, Steven M. Larson, David G. Pfister, James A Fagin, Alan Loh Ho
Publikováno v:
Journal of Clinical Oncology. 40:6089-6089
6089 Background: A pilot study showed MEK inhibition could enhance radioiodine (RAI) avidity/efficacy in 5 RAS mutant (MUT), RAI-refractory (RAIR) thyroid cancer (TC) patients (pts). This phase 2 trial with the MEK 1/2 inhibitor trametinib (tram) was
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e106868 (2014)
Because of their chemical properties and multiday half lives, iodine-124 and zirconium-89 are being used in a growing number of PET imaging studies. Some aspects of their quantitation, however, still need attention. For (89)Zr the PET images should,
Externí odkaz:
https://doaj.org/article/184c742fe0ce45958d34e33ddf739efb
Autor:
Neeta, Pandit-Taskar, Pat B, Zanzonico, Kim, Kramer, Milan, Grkovski, Edward K, Fung, Weiji, Shi, Zhigang, Zhang, Serge K, Lyashchenko, Alex M, Fung, Keith S, Pentlow, Jorge A, Carrasquillo, Jason S, Lewis, Steven M, Larson, Nai-Kong V, Cheung, John L, Humm
Publikováno v:
J Nucl Med
Radiation dose estimations are key for optimizing therapies. We studied the role of (124)I-omburtamab (8H9) given intraventricularly in assessing the distribution and radiation doses before (131)I-omburtamab therapy in patients with metastatic leptom
Autor:
Bradley J Beattie, Daniel L J Thorek, Charles R Schmidtlein, Keith S Pentlow, John L Humm, Andreas H Hielscher
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e31402 (2012)
There has been recent and growing interest in applying Cerenkov radiation (CR) for biological applications. Knowledge of the production efficiency and other characteristics of the CR produced by various radionuclides would help in accessing the feasi
Externí odkaz:
https://doaj.org/article/9d5e0ed9f16b4a379153b71f60f94e28